Lifeward Ltd. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Lifeward Ltd. on August 13, 2025. The filing reports the appointment of Almog Adar as Chief Financial Officer (CFO) and principal financial officer, effective August 1, 2025. Mr. Adar previously served as the Company's Vice President of Finance and Chief Accounting Officer.
Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change is the leadership transition within the finance department. Mr. Adar's promotion from Vice President of Finance to CFO represents an internal succession plan. No changes to the Company's business operations, financial results, or capital structure are disclosed in this document.
Compensation, Outlook, and Risks
Management commentary is limited to the announcement of the appointment. The filing details the following compensatory arrangements for Mr. Adar:
- Base Salary: $315,000 annually.
- Performance Bonus: Up to 35% of base salary. For the period through December 31, 2025, this includes a $80,000 retention payment (paid in two installments) and eligibility for an additional 7% of base salary based on individual metrics.
- Equity Grant: Option to purchase 225,000 ordinary shares, vesting in four equal annual installments.
- Severance:
- Standard Termination: 6 months of base salary, prorated target bonus, and health insurance reimbursement.
- Change of Control: 12 months of base salary, lump-sum target bonus, health insurance reimbursement, and accelerated vesting of all unvested equity.
The agreement includes standard non-solicitation, non-competition, and confidentiality covenants. No specific risks, contingencies, or unusual items regarding the Company's financial health are disclosed.
Key Facts for Investor Verification
- Verify the effective date of the CFO appointment (August 1, 2025) and the transition timeline.
- Review the full text of the Amended Employment Agreement (to be filed as an exhibit to the Q3 2025 Form 10-Q) for detailed vesting schedules and performance metrics.
- Confirm the total potential cash and equity compensation value relative to the Company's current market capitalization and cash position.
- Monitor future filings for any changes to the Company's financial reporting or strategy under the new CFO leadership.